Oramed Pharmaceuticals (XTAE:ORMP) Institutional Ownership: 7.44% (As of Aug. 03, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTAE:ORMP Oramed Pharmaceuticals Inc XTAE:ORMP
23 GF Score
Price ₪12.72
! 4 Warning Signs
View Full Analysis

What is Oramed Pharmaceuticals Institutional Ownership?

Oramed Pharmaceuticals XTAE:ORMP -5.78% 23 Institutional Ownership is 7.44% as of Aug. 03, 2026. GuruFocus rates XTAE:ORMP with a GF Score™ of 23/100. The stock has 4 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Oramed Pharmaceuticals's institutional ownership is 7.44%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Oramed Pharmaceuticals's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Oramed Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 84.51%.

Oramed Pharmaceuticals Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Oramed Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oramed Pharmaceuticals Institutional Ownership Chart

Oramed Pharmaceuticals Historical Data

The historical data trend for Oramed Pharmaceuticals can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 1.05 1.04 1.04 1.09 1.12 0.93 1.15 1.17 1.19 7.44
XTAE:ORMP
23GF Score
Oramed Pharmaceuticals Inc XTAE:ORMP
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oramed Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 7.44% mean?
Oramed Pharmaceuticals (XTAE:ORMP) has a Institutional Ownership of 7.44% as of Aug. 03, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Oramed Pharmaceuticals and its competitors.
Is Oramed Pharmaceuticals' Institutional Ownership too high?
Oramed Pharmaceuticals' current Institutional Ownership is 7.44%. Overall, Oramed Pharmaceuticals has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Oramed Pharmaceuticals' Institutional Ownership compare to CAMP and PYXS?
Oramed Pharmaceuticals' Institutional Ownership of 7.44% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Oramed Pharmaceuticals and its competitors. Oramed Pharmaceuticals's current Institutional Ownership is 7.44%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oramed Pharmaceuticals stock overvalued right now?
Oramed Pharmaceuticals (XTAE:ORMP) has a current Institutional Ownership of 7.44%. The current Institutional Ownership is 7.44%. Oramed Pharmaceuticals' overall GF Score™ is 23/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Oramed Pharmaceuticals (XTAE:ORMP), the current Institutional Ownership is 7.44% as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oramed Pharmaceuticals Business Description

Other Exchanges ORMP:USAOJU1:Germany
Address 1185 Avenue of the Americas, Third Floor, New York, NY, USA, 10036
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.
23GF Score

Get the complete analysis for XTAE:ORMP

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪12.72
Price